ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 001,80
-0,48%
Dow Jones
38 798,99
-0,22%
DAX
18 557,27
-0,48%
Brent Oil
79,395
0,00%
Bitcoin
69 232,52
-0,14%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Immunocore Holdings PLC (IMCR)

  7. Immunocore Holdings PLC (IMCR) Actualités

IMCR Immunocore Holdings PLC

41,68
-1,01 (-2,37%)
08 Juin 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Immunocore Holdings PLC IMCR NASDAQ Certificat de dépôt
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
-1,01 -2,37% 41,68 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
42,61 41,37 43,115 41,68 42,69
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
01/6/202414:00GLOBEImmunocore presents KIMMTRAK clinical data demonstrating..
31/5/202422:21EDGAR2Form 8-K - Current report
31/5/202422:05GLOBEImmunocore reports updated Phase 1 data of brenetafusp..
30/5/202422:00GLOBEImmunocore to present at the Jefferies Global Healthcare..
29/5/202413:00GLOBEImmunocore converts Phase 2/3 TEBE-AM clinical trial into..
28/5/202422:17EDGAR2Form 8-K - Current report
28/5/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/5/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/5/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/5/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/5/202422:50EDGAR2Form 8-K - Current report
08/5/202413:13EDGAR2Form 8-K - Current report
08/5/202413:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/5/202413:00GLOBEImmunocore reports first quarter financial results and..
24/4/202416:00GLOBEImmunocore announces upcoming presentation and posters at..
04/4/202422:00GLOBEImmunocore to present at upcoming investor conferences
05/3/202422:30GLOBEImmunocore presented two posters at CROI 2024
01/3/202413:00GLOBEImmunocore to present at upcoming investor conferences
28/2/202422:19EDGAR2Form 8-K - Current report
28/2/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202413:34GLOBEImmunocore reports fourth quarter and full year 2023..
28/2/202413:33EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
27/2/202400:46EDGAR2Form 144 - Report of proposed sale of securities
22/2/202413:00GLOBEImmunocore announces clinical trial collaboration and supply..
21/2/202422:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202413:00GLOBEImmunocore to report fourth quarter and full year 2023..
02/2/202422:05EDGAR2Form 8-K - Current report
31/1/202405:30GLOBEImmunocore Prices Upsized Convertible Senior Notes Offering
29/1/202423:06EDGAR2Form 8-K - Current report
29/1/202422:05GLOBEImmunocore Announces Proposed Convertible Senior Notes..
05/1/202422:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202413:19EDGAR2Form 8-K - Current report
05/1/202413:00GLOBEImmunocore announces strategic priorities and pipeline..
03/1/202423:55EDGAR2Form 144 - Report of proposed sale of securities
03/1/202413:00GLOBEImmunocore to present at the 42nd Annual J.P. Morgan..
02/1/202422:57EDGAR2Form 3 - Initial statement of beneficial ownership of..
02/1/202412:25EDGAR2Form 8-K - Current report
27/12/202323:30EDGAR2Form 144 - Report of proposed sale of securities
20/12/202319:54EDGAR2Form 144 - Report of proposed sale of securities
01/12/202302:33EDGAR2Form 144 - Report of proposed sale of securities
30/11/202310:00GLOBELevicept Appoints Eliot Forster as CEO
16/11/202315:51EDGAR2Form 144 - Report of proposed sale of securities
07/11/202313:09EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/11/202313:00GLOBEImmunocore Reports Third Quarter 2023 Financial Results and..
07/11/202301:20EDGAR2Form 144 - Report of proposed sale of securities
01/11/202321:01GLOBEImmunocore announces upcoming poster presentations at SITC..
30/10/202321:30GLOBEImmunocore to present at upcoming investor conferences

Dernières Valeurs Consultées

NASDAQ
IMCR
Immunocore
MRTX
OMCBTC
OrmeCash
ASX
MNDKOF
EU
NL0010525473
Orange Lion 2013 10 RMBS...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés